Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.

Abstract

Already published data were further analyzed regarding the association between the CHEK2*1100delC germ line mutation and estrogen receptor (ER) status in patients with breast cancer. The CHEK2*1100delC mutation was more prevalent among the patients with a positive ER status (4.2% versus 1.0%). An ER-negative status was beside CHEK2*1100delC mutation and… (More)

Topics

  • Presentations referencing similar topics